In this line, tonabersat, a compound active against neurogenic inflammation proposed in the treatment for epilepsy and as a prophylactic treatment for migraine with aura, two frequent comorbidities, prevents inflammatory damage in the CNS by blocking Cx43 HCs (Kim et al., 2017). This evidence concerns the gene GJA1 and migraine disorder.